New Zealand Institute for Cancer Research TrustProfiling of genome-wide epigenetic signatures to predict patient response to melanoma immunotherapy RNA-Sequencing of 74 New Zealand melanoma cell lines of the NZM cell line panel, and analysis of the resulting data Does epigenetic status determine the expression of immune checkpoint PD-L1 expression in melanoma? The genes of life and death: a role for placental-specific […]
Profiling of genome-wide epigenetic signatures to predict patient response to melanoma immunotherapy
Does epigenetic status determine the expression of immune checkpoint PD-L1 expression in melanoma?
The genes of life and death: a role for placental-specific genes in cancer?
Role of epigenetic alterations in causing aggressive phenotypes in melanoma cells